Back to search
FDAFDA · Food and drugs·Recall number D-0768-2026

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51

Published August 19, 2026 · Recall initiated: July 30, 2026

Summary

FDA records drug Class II recall D-0768-2026, published August 19, 2026 and initiated July 30, 2026. Recalling firm: Heritage Pharmaceuticals Inc; Status: Ongoing; Lot: Lot #: 2411550, Exp. 2026/NOV. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email if CLINDAMYCIN PALMITATE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Manufacturer
Heritage Pharmaceuticals Inc
Distributor
Nationwide within the U.S
Lot
Lot #: 2411550, Exp. 2026/NOV.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51 recalled?

Yes. FDA published recall D-0768-2026 on August 19, 2026. Reported hazard: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CLINDAMYCIN PALMITATE HYDROCHLORIDE.